SMGT-GLP-1, with its unique mechanism of action, has already achieved significant results in diabetes treatment and weight management
Since then, several GLP-1s for obesity have been approved for new indications such as secondary cardiovascular risk reduction (Wegovy), sleep apnea (Zepbound) and metabolic dysfunction-associated steatohepatitis or MASH (Wegovy)
The concern is that by stimulating melanocytes (the pigment-producing cells in your skin), you could theoretically stimulate abnormal or cancerous cells as well
This is especially good news if your skin is prone to: Redness or flushing Post-treatment sensitivity Chronic irritation or reactivity Barrier breakdown or dryness With regular use, GHK-Cu can help interrupt the inflammation cycle and lay the groundwork for long-term skin health
doi:10.1007/s00213-003-1675-8
Damaged vials may compromise peptide quality and stability during handling